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Introduction 
Valosin-containing protein (VCP) is a hexameric AAA+-type ATPase with a central 
role in various cellular activities, including cell cycle control, membrane fusion and 
the ubiquitin–proteasome degradation pathway. Mutations in the VCP gene have been 
associated with a variety of disorders, including distal myopathy with rimmed 
vacuoles, Paget’s disease of the bone, frontotemporal dementia, amyotrophic lateral 
sclerosis, Charcot-Marie-Tooth disease type 2, cardiomyopathy and Parkinson’s 
disease (PD) [1]. Meige syndrome is a type of cranial dystonia with blepharospasm 
and oromandibular dystonia sometimes associated with complex movement of lower 
facial muscles, mouth, jaw, tongue, pharyngeal and cervical muscles [2]. We report a 
patient with Meige syndrome, a mutation in VCP, and a myopathy 
Case report 
A 62-year old man presented with a 14-year history of a steppage gait. Clinical 
evaluation revealed weakness of ankle dorsiflexion, graded as 2/5 on the Medical 
Research Council scale bilaterally.  Creatine kinase (CK) level was mildly elevated at 
568 IU/L ( normal range 25–190). Needle electromyography (EMG) demonstrated 
small amplitude, short duration, polyphasic motor unit action potentials, with early 
recruitment and small amounts of fibrillation potentials and positive sharp waves. 
Nerve conduction studies were normal. Biopsy of the tibialis anterior muscle revealed 
a myopathy with rimmed vacuoles (Figure 1). Subsequent genetic testing revealed a 
heterozygous missense mutation c.476G>A (p.R159H) in exon 5 of the VCP gene, 
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which was previously described in another Greek family with a dominantly-inherited 
syndrome of myopathy, dementia and an ALS-like syndrome in members of 
consecutive generations [3]. Our patient had no evidence of Paget’s disease of bone 
and no cognitive deficits on neuropsychological evaluation. His 21-year-old son also 
had high a CK level (400 IU/L) and an EMG with findings similar to but less severe 
than  those of his father.  He declined genetic testing. There was no other family 
history of myopathy, Paget’s disease of bone or cognitive decline. The patient also 
carries a diagnosis of Meige syndrome with involuntary tonic spasms of the 
orbicularis oculi and oromandibular muscles, without eyelid opening apraxia. The 
first symptoms of eye closure spasms appeared at the age of 54 years and slowly 
spread to involve the oromandibular muscles and the platysma within the next five 
years. OnabotulinumtoxinA injections had a moderate positive effect on the muscle 
spasms, but produced ptosis and diplopia. Injection sessions began with small doses 
(2.5 U at 3 locations in the pretarsal orbicularis oculi muscles of each eye) and were 
gradually increased to 20 U per eye (5 U in three pretarsal and 2.5 U in two orbital 
orbicularis oculi sites). The latter dose caused severe bilateral ptosis that lasted 4 
weeks.  
Discussion 
Rare variants in the VCP gene may be more clinically important than is usually the 
case with other genes, because the protein appears to be intolerant to loss of function 
and missense mutations [1]. For example the I27V missense variant with an allele 
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frequency of 0.05%, has been described several times as being potentially pathogenic 
and has been identified in PD [1]. Moreover, immunohistochemical studies have 
demonstrated the presence of VCP in the peripheral portion of Lewy bodies, in 
Marinesco bodies that are seen in the nuclei of aged nigral neurons and in Lewy 
neurites in neuronal processes in PD, suggesting that the protein could be involved in 
the formation or degradation of various neuronal inclusions in neurodegenerative 
diseases such as a-synucleinopathies [4, 5]. I VCP is also known to play a pivotal role 
in TAR DNA-binding protein 43 (TDP-43) dysregulation and is therefore involved in 
TDP-43 pathology, which is implicated in the mechanisms of neurodegeneration in 
many Lewy body-related diseases [6, 7]. Based on these findings, it can be 
hypothesized that VCP variants may confer a risk for common degenerative diseases, 
including PD. Meige syndrome pathophysiology involves many brain regions and 
neural networks, mostly sensorimotor cortex, brain stem, and basal ganglia. 
Neuropathological studies from patients with Meige syndrome have revealed the 
presence of Lewy bodies in the brainstem and basal ganglia of 25% of autopsied cases 
[8]. In addition patients with Meige syndrome are more prone to develop PD than 
aged-matched controls [9].  VCP-related myopathy is an extremely rare disease with a 
prevalence of 0.66/100,000 population[1], while Meige syndrome has an estimated 
prevalence of less than 32 per million [10]. In view of their rarity, their coexistence in 
the same patient may not be coincidental and may be linked to an underlying 
pathological mechanism. Collectively, these data suggest that at least some patients 
with Meige disease share a common pathophysiology with PD patients that includes 
This article is protected by copyright. All rights reserved.
VCP myopathy and Meige syndrome  
 
 
basal ganglia dysfunction and Lewy body formation [10]. It is possible that VCP 
mutations lead to the formation of Lewy bodies in basal ganglia, but that in the 
majority of patients this basal ganglia dysfunction is subclinical. However, in a small 
proportion of patients, such as the one presented here, this could cause or predispose 
to the development of Meige syndrome and in a small minority of patients, as the 
basal ganglia lesion becomes more severe, it could result in PD.  
While there are several reports of patients with VCP-related PD [1] and the VCP 
protein itself is a component of Lewy bodies [4], there has been no association with 
another movement disorder. The patient presented here demonstrated findings of 
typical Meige syndrome and carried a VCP gene mutation. The causal relationship 
between the VCP defect and Meige syndrome cannot be established by this single 
patient. However, the association of VCP with PD and Lewy bodies in basal ganglia 
suggests a possible pathological link. Further pathological studies are necessary to 
validate this hypothesis. This case adds to the increasing body of literature on VCP 
mutations by identifying a possible novel presentation. 
Abbreviations 
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Figure legends 
Figure 1.Skeletal muscle section from tibialis anterior obtained at age 62 stained using 
modified Gomori trichrome showing multiple rimmed vacuoles (arrows) (x40). Scale 
bar = 70 µm. 
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